OncoSec Medical CEO Daniel O'Connor's 2020 pay rises 15% to $1.4M
OncoSec Medical reports 2020 executive compensation
By ExecPay News
Published: March 18, 2021
OncoSec Medical reported fiscal year 2020 executive compensation information on March 18, 2021.
In 2020, three executives at OncoSec Medical received on average a compensation package of $837K, a 2% decrease compared to previous year.
Average pay of disclosed executives at OncoSec Medical
Daniel J. O'Connor, Chief Executive Officer, received $1.4M in total, which increased by 15% compared to 2019. 38% of O'Connor's compensation, or $513K, was in salary. O'Connor also received $327K in bonus, $502K in option awards, as well as $11K in other compensation.
Kellie Malloy Foerter, Chief Operating Officer, received a compensation package of $769K. 43% of the compensation package, or $328K, was in salary.
Robert J. DelAversano, Principal Accounting Officer and Controller, earned $390K in 2020.
OncoSec Medical's fiscal year ends on July 31.
Related executives
You may also like
Source: SEC filing on March 18, 2021.